Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV.
Alrubayyi A, Gea-Mallorquí E, Touizer E, Hameiri-Bowen D, Kopycinski J, Charlton B, Fisher-Pearson N, Muir L, Rosa A, Roustan C, Earl C, Cherepanov P, Pellegrino P, Waters L, Burns F, Kinloch S, Dong T, Dorrell L, Rowland-Jones S, McCoy LE, Peppa D. Alrubayyi A, et al. Among authors: kinloch s. Nat Commun. 2021 Oct 5;12(1):5839. doi: 10.1038/s41467-021-26137-7. Nat Commun. 2021. PMID: 34611163 Free PMC article.
Failure to seroconvert after two doses of BNT162b2 SARS-CoV-2 vaccine in a patient with uncontrolled HIV.
Touizer E, Alrubayyi A, Rees-Spear C, Fisher-Pearson N, Griffith SA, Muir L, Pellegrino P, Waters L, Burns F, Kinloch S, Rowland-Jones S, Gupta RK, Gilson R, Peppa D, McCoy LE. Touizer E, et al. Among authors: kinloch s. Lancet HIV. 2021 Jun;8(6):e317-e318. doi: 10.1016/S2352-3018(21)00099-0. Lancet HIV. 2021. PMID: 34087093 Free PMC article. No abstract available.
Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV.
Alrubayyi A, Gea-Mallorquí E, Touizer E, Hameiri-Bowen D, Kopycinski J, Charlton B, Fisher-Pearson N, Muir L, Rosa A, Roustan C, Earl C, Cherepanov P, Pellegrino P, Waters L, Burns F, Kinloch S, Dong T, Dorrell L, Rowland-Jones S, McCoy LE, Peppa D. Alrubayyi A, et al. Among authors: kinloch s. bioRxiv [Preprint]. 2021 Feb 16:2021.02.15.431215. doi: 10.1101/2021.02.15.431215. bioRxiv. 2021. PMID: 33619489 Free PMC article. Updated. Preprint.
No evidence of neuronal damage as measured by neurofilament light chain in a HIV cure study utilising a kick-and-kill approach.
Alagaratnam J, Stöhr W, Toombs J, Heslegrave A, Zetterberg H, Gisslén M, Pett S, Nelson M, Clarke A, Nwokolo N, Johnson MA, Khan M, Hanke T, Kopycinski J, Dorrell L, Fox J, Kinloch S, Underwood J, Pace M, Frater J, Winston A, Fidler S; RIVER trial study group. Alagaratnam J, et al. Among authors: kinloch s. J Virus Erad. 2021 Sep 14;7(3):100056. doi: 10.1016/j.jve.2021.100056. eCollection 2021 Sep. J Virus Erad. 2021. PMID: 34611495 Free PMC article.
Immunological biomarkers predict HIV-1 viral rebound after treatment interruption.
Hurst J, Hoffmann M, Pace M, Williams JP, Thornhill J, Hamlyn E, Meyerowitz J, Willberg C, Koelsch KK, Robinson N, Brown H, Fisher M, Kinloch S, Cooper DA, Schechter M, Tambussi G, Fidler S, Babiker A, Weber J, Kelleher AD, Phillips RE, Frater J. Hurst J, et al. Among authors: kinloch s. Nat Commun. 2015 Oct 9;6:8495. doi: 10.1038/ncomms9495. Nat Commun. 2015. PMID: 26449164 Free PMC article. Clinical Trial.
Dynamics of immunoglobulin sequence diversity in HIV-1 infected individuals.
Hoehn KB, Gall A, Bashford-Rogers R, Fidler SJ, Kaye S, Weber JN, McClure MO; SPARTAC Trial Investigators; Kellam P, Pybus OG. Hoehn KB, et al. Philos Trans R Soc Lond B Biol Sci. 2015 Sep 5;370(1676):20140241. doi: 10.1098/rstb.2014.0241. Philos Trans R Soc Lond B Biol Sci. 2015. PMID: 26194755 Free PMC article.
64 results